-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
LogicBio Therapeutics, Inc. quarterly/annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate from 2017 to 2021.
- LogicBio Therapeutics, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending March 31, 2022 was $170K, a 22% decline year-over-year.
- LogicBio Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $844K, a 5.17% decline from 2020.
- LogicBio Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2020 was $890K, a 100% increase from 2019.
- LogicBio Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2019 was $445K.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Growth (%)